CA1231281A - Dispositif inhibiteur pour systeme de perfusion prgrammable - Google Patents

Dispositif inhibiteur pour systeme de perfusion prgrammable

Info

Publication number: CA1231281A
Authority: CA; Canada
Prior art keywords: infusion; rate; medication; pulses; unit
Prior art date: 1982-12-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000486976A

Other languages

English (en)

Inventor

Robert E. Fischell

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Johns Hopkins University

Original Assignee

Johns Hopkins University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-12-17

Filing date

1985-07-17

Publication date

1988-01-12

1985-07-17 Application filed by Johns Hopkins University filed Critical Johns Hopkins University

1985-07-17 Priority to CA000486976A priority Critical patent/CA1231281A/fr

1988-01-12 Application granted granted Critical

1988-01-12 Publication of CA1231281A publication Critical patent/CA1231281A/fr

Status Expired legal-status Critical Current

Links

238000001802 infusion Methods 0.000 title claims abstract description 98
230000002401 inhibitory effect Effects 0.000 title claims abstract description 24
239000003814 drug Substances 0.000 claims abstract description 148
229940079593 drug Drugs 0.000 claims abstract description 146
238000002513 implantation Methods 0.000 claims description 2
230000036962 time dependent Effects 0.000 claims description 2
239000000919 ceramic Substances 0.000 description 18
230000000541 pulsatile effect Effects 0.000 description 14
238000004891 communication Methods 0.000 description 12
239000012530 fluid Substances 0.000 description 12
230000000638 stimulation Effects 0.000 description 11
210000001124 body fluid Anatomy 0.000 description 10
239000010839 body fluid Substances 0.000 description 10
239000007788 liquid Substances 0.000 description 9
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
238000000034 method Methods 0.000 description 8
238000007920 subcutaneous administration Methods 0.000 description 8
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
230000007257 malfunction Effects 0.000 description 7
230000006870 function Effects 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
102000004877 Insulin Human genes 0.000 description 4
108090001061 Insulin Proteins 0.000 description 4
229940125396 insulin Drugs 0.000 description 4
235000012054 meals Nutrition 0.000 description 4
AJDIZQLSFPQPEY-UHFFFAOYSA-N 1,1,2-Trichlorotrifluoroethane Chemical compound FC(F)(Cl)C(F)(Cl)Cl AJDIZQLSFPQPEY-UHFFFAOYSA-N 0.000 description 3
230000009471 action Effects 0.000 description 3
239000000356 contaminant Substances 0.000 description 3
230000009977 dual effect Effects 0.000 description 3
229920001971 elastomer Polymers 0.000 description 3
230000003993 interaction Effects 0.000 description 3
230000000670 limiting effect Effects 0.000 description 3
238000012544 monitoring process Methods 0.000 description 3
238000005086 pumping Methods 0.000 description 3
230000004044 response Effects 0.000 description 3
238000007789 sealing Methods 0.000 description 3
230000000007 visual effect Effects 0.000 description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
241001481828 Glyptocephalus cynoglossus Species 0.000 description 2
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
OJIJEKBXJYRIBZ-UHFFFAOYSA-N cadmium nickel Chemical compound [Ni].[Cd] OJIJEKBXJYRIBZ-UHFFFAOYSA-N 0.000 description 2
230000008859 change Effects 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000010586 diagram Methods 0.000 description 2
230000003467 diminishing effect Effects 0.000 description 2
NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 2
230000037406 food intake Effects 0.000 description 2
235000012631 food intake Nutrition 0.000 description 2
229910021397 glassy carbon Inorganic materials 0.000 description 2
229960002897 heparin Drugs 0.000 description 2
229920000669 heparin Polymers 0.000 description 2
239000007943 implant Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
229910052744 lithium Inorganic materials 0.000 description 2
238000009877 rendering Methods 0.000 description 2
238000012360 testing method Methods 0.000 description 2
208000032368 Device malfunction Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000220010 Rhode Species 0.000 description 1
241000120694 Thestor Species 0.000 description 1
230000010100 anticoagulation Effects 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
235000021152 breakfast Nutrition 0.000 description 1
238000010276 construction Methods 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000003205 diastolic effect Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000000806 elastomer Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229960001031 glucose Drugs 0.000 description 1
231100001261 hazardous Toxicity 0.000 description 1
230000035876 healing Effects 0.000 description 1
230000008676 import Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
238000002483 medication Methods 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
239000003507 refrigerant Substances 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
230000011664 signaling Effects 0.000 description 1
238000004088 simulation Methods 0.000 description 1
210000003625 skull Anatomy 0.000 description 1
235000011888 snacks Nutrition 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
210000001835 viscera Anatomy 0.000 description 1

Landscapes

Infusion, Injection, And Reservoir Apparatuses (AREA)

CA000486976A 1982-12-17 1985-07-17 Dispositif inhibiteur pour systeme de perfusion prgrammable Expired CA1231281A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000486976A CA1231281A (fr)	1982-12-17	1985-07-17	Dispositif inhibiteur pour systeme de perfusion prgrammable

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA000417979A CA1193934A (fr)	1982-12-17	1982-12-17	Systeme implantable et programmable pour la perfusion de medicaments
CA000486976A CA1231281A (fr)	1982-12-17	1985-07-17	Dispositif inhibiteur pour systeme de perfusion prgrammable

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000417979A Division CA1193934A (fr)	1982-12-17	1982-12-17	Systeme implantable et programmable pour la perfusion de medicaments

Publications (1)

Publication Number	Publication Date
CA1231281A true CA1231281A (fr)	1988-01-12

Family

ID=4124170

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
CA000417979A Expired CA1193934A (fr)	1982-12-17	1982-12-17	Systeme implantable et programmable pour la perfusion de medicaments
CA000486976A Expired CA1231281A (fr)	1982-12-17	1985-07-17	Dispositif inhibiteur pour systeme de perfusion prgrammable
CA000486993A Expired CA1231282A (fr)	1982-12-17	1985-07-17	Dispositif de pompage pour systeme de perfusion programmable
CA000486992A Expired CA1206832A (fr)	1982-12-17	1985-07-17	Dispositif d'alarme pour systeme de perfusion programmable

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CA000417979A Expired CA1193934A (fr)	1982-12-17	1982-12-17	Systeme implantable et programmable pour la perfusion de medicaments

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
CA000486993A Expired CA1231282A (fr)	1982-12-17	1985-07-17	Dispositif de pompage pour systeme de perfusion programmable
CA000486992A Expired CA1206832A (fr)	1982-12-17	1985-07-17	Dispositif d'alarme pour systeme de perfusion programmable

Country Status (1)

Country	Link
CA (4)	CA1193934A (fr)

1982
- 1982-12-17 CA CA000417979A patent/CA1193934A/fr not_active Expired
1985
- 1985-07-17 CA CA000486976A patent/CA1231281A/fr not_active Expired
- 1985-07-17 CA CA000486993A patent/CA1231282A/fr not_active Expired
- 1985-07-17 CA CA000486992A patent/CA1206832A/fr not_active Expired

Also Published As

Publication number	Publication date
CA1193934A (fr)	1985-09-24
CA1206832A (fr)	1986-07-02
CA1231282A (fr)	1988-01-12

Legal Events

Date	Code	Title	Description
2005-01-12	MKEX	Expiry

Publication	Publication Date	Title
US4373527A (en)	1983-02-15	Implantable, programmable medication infusion system
EP0124546B1 (fr)	1991-08-28	Systeme d'infusion de medicaments
US4360019A (en)	1982-11-23	Implantable infusion device
US4784645A (en)	1988-11-15	Apparatus for detecting a condition of a medication infusion system and providing an informational signal in response thereto
AU2005225083B2 (en)	2011-08-04	Implantable pump with intergrated refill detection
US8491547B2 (en)	2013-07-23	Septum monitoring system and method for an implantable therapeutic substance delivery device
US6635049B1 (en)	2003-10-21	Drug bolus delivery system
US7887505B2 (en)	2011-02-15	Flow condition sensor assembly for patient infusion device
EP2136870B1 (fr)	2011-12-28	Détection de l'entrée d'une aiguille dans un orifice d'un dispositif de perfusion
US4871351A (en)	1989-10-03	Implantable medication infusion system
US8613719B2 (en)	2013-12-24	Dosage sensing unit with tactile feedback
US20040015131A1 (en)	2004-01-22	Flow restriction system and method for patient infusion device
EP1181067A1 (fr)	2002-02-27	Dispositif de perfusion fonctionnant au gaz, pourvu d'une valve de limitation a la sortie du medicament
JPS59115049A (ja)	1984-07-03	投薬プログラムシステム
GB2174218A (en)	1986-10-29	Programmable infusion system for medication
CA1231281A (fr)	1988-01-12	Dispositif inhibiteur pour systeme de perfusion prgrammable